29/03/2021

V International School of the ARTROMASTER Association

On March 19-20th, the V International School of the ARTROMASTER Association took place in Kazan.

More than 200 traumatologists from Russian cities and other countries attended the event, in order to discuss new tendencies of treatment and diagnosis for trauma patients.

The products of Fidia Pharma, a leader in the development and production of hyaluronic acid for intra-articular administration, aroused keen interest among the participants of the event.

At the company's booth, doctors could get the latest scientific data confirming the effectiveness and safety of Fidia's products (Hyalone, Hymovis, Hyalubrix), as well as ask clarifying questions to the company's employees.

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Other product websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Russia product portfolio focalizes primarily on joint healthcare.

Fidia Pharma Russia is focused on providing consumers with innovative products that offer quality, safety and performance.